Department of Anaesthesiology and Critical Care

Permanent URI for this community

https://scholar.sun.ac.za/handle/10019.1/136

Browse

Browsing Department of Anaesthesiology and Critical Care by browse.metadata.advisor "Johnson, Marianne"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    The Prevalence of Propofol Contamination in the Tygerberg Theatre Complex
    (Stellenbosch : Stellenbosch University, 2020-12) Drude, Carmen; Johnson, Marianne; Stellenbosch University. Faculty of Medicine and Health Sciences. Dept. of Anaesthesiology and Critical Care.
    ENGLISH ABSTRACT: Propofol is a widely used intravenous anaesthetic agent. Soon after its introduction into the market, propofol-related postoperative infections were reported. It was determined that the emulsion supports growth and manufacturers provided strict aseptic guidelines with regards to propofol usage, but it has been shown that clinicians in South Africa do not adhere to these guidelines. The primary objective of our observational study was to determine the prevalence of contamination of syringes containing propofol (Fresenius’ Propoven® 1%, Fresenius Kabi, Sweden) in the Tygerberg Hospital Theatre Complex. Samples of syringes containing propofol were collected from various randomised operating theatres over a period of 15 days and specimens cultured and tested for growth of organisms. The secondary objective was to differentiate between contamination occurring in e mergency and elective surgery operating theatres and investigate the difference in propofol contamination when used by junior versus more senior anaesthetists. We demonstrated an unacceptably high propofol contamination prevalence of 41.8% (95% CI: 32.5%, 51.6%). Coagulase negative staphylococcus (CONS) was the most prevalent organism. Overall, 58.18% of samples demonstrated no growth after 2 days. Regarding our secondary objective, there was no statistically significant difference regarding the prevalence of propofol contamination of samples taken from the emergency and elective operating theatres (p = 0.95; risk ratio 1.02; 95% CI: 0.55; 1.89). Propofol syringes handled by senior versus junior anaesthetists revealed a similar result (p = 0.65; risk ratio 0.90; 95% CI: 0.58; 1.41). CONS are often contaminants and the bulk of organisms we cultured are non-pathogenic in healthyhosts but can be lethal in immunocompromised patients. Presence of commensals is also a warning that any other pathogens (including viruses) that may be present on the anaesthetist’s hands or in the environment may also contaminate the propofol. The presence of human commensals as well as environmental organisms in the propofol syringes are avoidable and a zero-contamination rate should be aspired to in all interactions with patients.